| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 524717 | Titan Biotech Titan Biotech Ltd | 30-May-2026 | Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the audited financial results (standalone and consolidated) and to recommend dividend if any. |
| 524695 | Asian Fertilizer Asian Fertilizers Ltd | 30-May-2026 | Asian Fertilizers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the audited financial results of the Company for the year ended 31st March 2026 through video conferencing. |
| 524624 | Gagan Gases Gagan Gases Ltd | 30-May-2026 | Gagan Gases Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited financial results for the quarter & Financial year ended on 31.03.2026. |
| 524602 | Bandaram Pharma Bandaram Pharma Packtech Ltd | 30-May-2026 | Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited Financial Statements (Standalone and Consolidated) along with Audit Report (Standalone and Consolidated) for the Quarter and Year ended 31.03.2026. |
| 524506 | Coral Labs. Coral Laboratories Ltd | 30-May-2026 | Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday May 30 2026 inter alia to consider and approve: 1. Standalone audited financial results for the quarter and financial year ended on March 31 2026; 2. Recommendation final dividend on equity shares of the Company for the year ended on March 31 2026 if any; 3. Appointment of Internal Auditor for the financial year 2026-27; 4. Appointment of Cost Auditor for the financial year 2026-27; 5. Any other business with the permission of chairman. |
| 524546 | Satiate Agri Satiate Agri Ltd | 30-May-2026 | Satiate Agri Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended on March 31 2026. |
| 524548 | Sharma E I Hosp. Sharma East India Hosp and Medical Research Ltd | 30-May-2026 | Quarterly Results & Audited Results Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. To consider and approve the Standalone Audited Financial Results along with Auditor Report for the year ended March 31, 2026, pursuant to regulation 33 of SEBI (LODR) Regulation, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. |
| 524396 | Biofil Chemicals Biofil Chemicals & Pharmaceuticals Ltd | 30-May-2026 | Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the fourth Quarter as well as Financial Year ended on 31st March 2026. |
| 524400 | Ishita Drugs Ishita Drugs & Industries Ltd | 30-May-2026 | Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To consider approve and take on records the Audited Financial Results of the Company for the quarter and year ended 31st March 2026 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 2. To consider and approve the Directors Report with the Annexure Corporate Governance Report Management Discussion and Analysis Report and Notice for convening the 33rd Annual General Meeting of the Company. 3. To consider the re-appointment of Internal Auditors of the Company for the year 2026-27. 4. To take on record Disclosure of Interest of Directors. 5. Any other matter with permission of the Chair. |
| 523842 | Super Tannery Super Tannery Ltd | 30-May-2026 | Final Dividend & Audited Results |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
